Junior Analyst (Student) - Seed Investments
Novo Holdings Seeds Investments team is looking for a Junior Analyst
Are you a 3rd-year bachelor’s student or did you recently start your master’s degree, and do you have an interest in life sciences, early-stage investing and company creation? Are you looking to join a purpose-driven global investment firm that combines financial returns with long term societal impact?
About Seeds Investments
Through partnering and direct investments, we champion the creation and development of groundbreaking biotech companies. We focus on nurturing early-stage projects with the potential to impact patients, offering both capital and access to our extensive network and expertise. Our approach combines rigorous scientific validation with seasoned entrepreneurial, strategic, and market insights, aiming to de-risk projects and enhance their success.
The Role
As a Junior Analyst in the Seeds Investments team, you will gain exposure to biotech venture capital investing and company creation while working alongside a team of seasoned investors with extensive international experiences in life sciences.
The role offers hands-on experience across the full investment lifecycle and provides a unique opportunity for both personal and professional development in a dynamic, ambitious and collaborative work environment.
Your tasks will include:
- Supporting the day-to-day management of our deal flow and CRM system
- Conducting scientific, commercial and strategic analyses of potential investments and their markets
- Collecting, structuring, and clearly communicating information on potential and existing investments
- Contributing to the broader investment analyses and ad hoc tasks within life sciences
You will join a dynamic team of 16 investment professionals based in our Hellerup office. The role is approximately 20 hours per week with flexibility around your studies, and work is expected to take place on-site.
Qualifications
We are ideally looking for applicants who:
- Are in the 3rd year of a bachelor’s degree or have recently started a master’s degree within life sciences, biomedical sciences, medicine, or a related field
- Have strong verbal and written communication skills in English
- Are proficient in MS Office, particularly Excel and PowerPoint .
- Possess strong analytical skills and the ability to balance big-picture thinking while maintaining attention to detail
- Have a genuine interest in life sciences investing, and a desire to develop professionally in a fast-paced environment
- Have achieved excellent academic performance
- Show initiative, responsibility, and a high level of reliability
- Are based locally to enable working on site with the Seeds Investments team
Working at Novo Holdings
Novo Holdings is a purpose-driven organization managing the assets of the Novo Nordisk Foundation to deliver long-term value and societal impact. As of year-end 2025, the foundation’s assets total EUR ~93 billion.
We strive to create an inclusive and development-focused environment. With a diverse team of over 200 professionals across offices in Copenhagen, London, Boston, San Francisco, Singapore, Shanghai, and Mumbai, we are committed to fostering professional growth and meaningful impact.
Application and Information
To apply, please send your CV, grade transcript, and other relevant documents by clicking on the “Apply Now” button. We encourage you to send your application as soon as possible and no later than March 25 2026.
The expected start date is June 1st 2026.
About Novo Holdings
Novo Holdings is a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation. Our purpose is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the Foundation’s assets.
Novo Holdings is headquartered in Copenhagen, Denmark, with additional offices in San Francisco, Boston, London, Singapore, Shanghai, and Mumbai. Novo Holdings is a leading global life sciences investor, investing in life science companies at all stages of development, with a portfolio of more than 170 companies. In addition to its life sciences activities, Novo Holdings manages a broad portfolio of public and private assets. As of year-end 2025, Novo Holdings had total assets of EUR 93 billion.